Jim O’Neill: Why antimicrobial resistance needs to be reviewed

Global Business

NIAD Via Flickr NIAD Via Flickr

The U.K. estimates that antimicrobial resistance could wipe $100 trillion from economic output by 2050. Some health experts accuse drug companies of not investing in updated antibiotics because they won’t see a return on the new treatments for around 20 years. 

British lawmaker Jim O’Neill is leading a review into antimicrobial resistance.

He told CCTV’s James Chau that China should take the lead on pushing the problem up the global agenda when it heads the G-20 next year.

Jim O'Neill: Why antimicrobial resistance needs to be reviewed

Jim O'Neill: Why antimicrobial resistance needs to be reviewed

The U.K. estimates that antimicrobial resistance could wipe $100 trillion from economic output by 2050. Some health experts accuse drug companies of not investing in updated antibiotics because they won't see a return on the new treatments for around 20 years. British lawmaker Jim O'Neill is leading a review into antimicrobial resistance. He told CCTV's James Chau that China should take the lead on pushing the problem up the global agenda when it heads the G-20 next year.